CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $1.44B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.04: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
9.66BCNY1.44B · vs all stocks (USD)
Trailing P/E
76.40xRevenue (TTM)
487.44MCNY72.49M · vs all stocks (USD)
Profit Margin
28.73%Beta
-0.2740xvs all stocks
52-Week Change
-13.76%vs all stocks
Market Capitalization
9.66BCNY1.44B · vs all stocks (USD)
Enterprise Value
11.00BCNY1.64B · vs all stocks (USD)
Trailing P/E
76.40xPEG Ratio
5.92xPrice to Sales (TTM)
21.56xPrice to Book (MRQ)
9.65xEnterprise to Revenue
22.56xEnterprise to EBITDA
140.87xGross Margin
11.86%Profit Margin
28.73%Operating Margin
-4.65%Return on Assets (TTM)
-1.45%Return on Equity (TTM)
13.45%Revenue (TTM)
487.44MCNY72.49M · vs all stocks (USD)
Revenue per Share (TTM)
0.1770CNYUpdated Aug 20, 2026Quarterly Revenue Growth
22.70%Gross Profit (TTM)
51.62MCNY7.68M · vs all stocks (USD)
EBITDA (TTM)
424.73MCNY63.16M · vs all stocks (USD)
Net Income (TTM)
140.03MCNY20.82M · vs all stocks (USD)
Operating Cash Flow (TTM)
37.68MCNY5.60M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-159.63MCNY-23.74M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
22.36MCNYFY2025 · Dec 31, 2025Revenue
465.12MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
398.58MCNYFY2025 · Dec 31, 2025Gross Profit
66.55MCNYFY2025 · Dec 31, 2025Operating Income
-38.09MCNY-5.67M · vs all stocks (USD)
Pre-tax Income
169.09MCNYFY2025 · Dec 31, 2025Income Tax Expense
36.41MCNYFY2025 · Dec 31, 2025Net Income
132.69MCNYFY2025 · Dec 31, 2025EBIT
174.70MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
424.73MCNYFY2025 · Dec 31, 2025Research & Development
24.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
27.64MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.95MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.61MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0519CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0519CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.72BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.72BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
132.69MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
8.70MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
331.89MCNYFY2025 · Dec 31, 2025Free Cash Flow
330.51MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
319.51MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
132.69MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.59MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
32.81MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
155.80MCNYFY2025 · Dec 31, 2025Capital Expenditures
1.38MCNYFY2025 · Dec 31, 2025Net Acquisitions
1.39KCNYFY2025 · Dec 31, 2025Purchase of Investments
-23.00MCNYFY2025 · Dec 31, 2025Sale of Investments
10.04MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-11.58MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
144.15MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-20.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-507.89KCNYFY2025 · Dec 31, 2025Other Financing Charges
52.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
176.11MCNYFY2025 · Dec 31, 2025Shares Outstanding
2.75BSharesUpdated Aug 20, 2026Float Shares
1.78BSharesUpdated Aug 20, 2026% Held by Insiders
27.05%vs all stocks
% Held by Institutions
2.56%vs all stocks
Total Cash (MRQ)
202.36MCNY30.09M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0730CNYUpdated Aug 20, 2026Total Debt (MRQ)
585.38MCNY87.05M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5188xCurrent Ratio (MRQ)
1.27xBook Value per Share (MRQ)
0.3960CNYUpdated Aug 20, 2026Total Assets
2.14BCNY317.56M · vs all stocks (USD)
Total Current Assets
705.91MCNYFY2025 · Dec 31, 2025Total Liabilities
1.11BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.43BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
622.23MCNYFY2025 · Dec 31, 2025Total Current Liabilities
491.08MCNYFY2025 · Dec 31, 2025Cash
319.51MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.01MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
320.52MCNYFY2025 · Dec 31, 2025Accounts Receivable
157.62MCNYFY2025 · Dec 31, 2025Inventory
40.42MCNYFY2025 · Dec 31, 2025Accounts Payable
48.10MCNYFY2025 · Dec 31, 2025Short-term Debt
213.89MCNYFY2025 · Dec 31, 2025Other Current Liabilities
44.71MCNYFY2025 · Dec 31, 2025Long-term Debt
364.70MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
20.12MCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.28BCNYFY2025 · Dec 31, 2025Retained Earnings
-2.70BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.02BCNY152.00M · vs all stocks (USD)
Treasury Stock
42.68MCNYFY2025 · Dec 31, 202552-Week Low
2.81CNYUpdated Aug 20, 202652-Week High
7.57CNYUpdated Aug 20, 202652-Week Change
-13.76%vs all stocks
Beta
-0.2740xvs all stocks
50-Day MA
3.84CNYUpdated Aug 20, 2026200-Day MA
4.26CNYUpdated Aug 20, 2026Avg 10-Day Volume
168.08MSharesUpdated Aug 20, 2026Avg 30-Day Volume
139.70MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.0500CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 20,824,001.682Operating Cash Flow (USD, TTM): 5,603,115.605
Financial Health
Altman Z-Score 4.04: safe zoneNotable
Altman Z-Score: 4.04
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $1.44B, above the global median of $1.15BNotable
Market cap (USD): 1,436,110,917.773Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Shandong Xinhua Pharmaceutical Company Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Genrix Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Hotgen Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Qingdao Haier Biomedical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
China Traditional Chinese Medicine Holdings Co. Limited
Tier 1ProductionApproval-Gated PipelineFlowInterface
Integra LifeSciences Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Jolly Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pacific Shuanglin Bio-Pharmacy Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Marksans Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Super Micro Computer Inc
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Xinjiang Zhundong Petroleum Technology Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Hefei Urban Construction Group Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated